How To Make IVF Successful The First Time?

No single action guarantees IVF success on the first attempt. Success rates depend on age, diagnosis, embryo quality, and factors outside anyone’s control. However, there is a clear set of evidence-backed steps that improve your odds: beginning body preparation 90 days before stimulation, optimising both egg and sperm quality, choosing a protocol matched to your profile, making a data-driven transfer decision (fresh vs frozen, SET vs DET), and understanding what the science actually says about the two-week wait. This guide covers all of it honestly.

The Honest Truth About “First Time” IVF Success

Before tactics, a fact worth stating clearly: IVF success on the first cycle is not the norm. It is the goal, and a realistic one for the right patients, but not a guarantee even with perfect preparation.

Live birth rates per IVF transfer, by age (approximate global benchmarks):

These are per-transfer figures, not per-cycle figures. If you retrieve multiple eggs and create multiple embryos, your cumulative success rate across all transfers from one egg collection is significantly higher. Many patients who do not succeed on their first transfer do succeed on a subsequent frozen embryo transfer from the same cycle.

Understanding this matters because the goal of “making IVF successful the first time” is really two goals: maximising the number and quality of embryos you create in the first egg collection, and giving each transfer the best possible environment for implantation. Both are within your influence, though not entirely within your control.

For a full breakdown of how success rates vary by diagnosis, embryo quality, and technique, see our guide on IVF success rates.

What You Can and Cannot Control?

Before investing effort in preparation, it helps to understand the categories clearly.

Within your influence:

• Egg and sperm quality (partially improvable over 90 days)
• Body weight, smoking, alcohol, and caffeine intake
• Thyroid function and Vitamin D levels
• Medication compliance and monitoring attendance
• Clinic and protocol selection
• Transfer strategy (fresh vs frozen, single vs double embryo)
• Emotional preparation and stress management

Largely outside your control:

• Age-related decline in egg quality
• Genetic abnormalities in embryos (the most common cause of IVF failure)
• Uterine anatomy issues discovered only after investigation
• The inherent unpredictability of biological processes

Knowing the distinction prevents misdirected effort. For example, spending weeks worrying about diet while skipping sperm analysis, or obsessing over post-transfer activity when the embryo’s genetic viability was determined before retrieval.

Phase 1: 90 Days Before Stimulation, The Most Impactful Window

The single most evidence-supported recommendation in IVF preparation is to start 90 days before your egg retrieval. The reason is biological: both eggs and sperm take approximately 90 days to mature. The quality of the gametes retrieved in your IVF cycle is largely determined by what happened in your body in the three months prior.

This is the window where lifestyle and supplementation changes have the greatest potential impact.

Egg Quality Optimisation

The key targets are mitochondrial energy production (required for the egg’s division process) and oxidative stress reduction.

CoQ10 (ubiquinol form, 200-600mg/day): The strongest supplementation evidence in reproductive medicine. CoQ10 supports mitochondrial function in maturing eggs. Ubiquinol is the reduced, more bioavailable form and is preferred, especially in patients over 35.

Methylfolate (400-800mcg/day): More bioavailable than folic acid, particularly important for women with MTHFR gene variants. Critical for embryo neural tube development in early pregnancy as well as egg quality.

Vitamin D (optimise to 40-60 ng/mL): Low Vitamin D is associated with poorer IVF outcomes. Blood test first, as many women in India are deficient. Supplement to optimise, not just to reach “normal range.”

DHEA (25-75mg/day, only under medical supervision): May benefit poor responders (low AMH, low antral follicle count). Contraindicated in PCOS. Do not self-prescribe. DHEA requires a doctor’s assessment of your specific profile.

Omega-3 fatty acids (2-3g/day, EPA+DHA): Supports egg membrane quality and reduces inflammatory markers. Well-tolerated and low risk.

Quit smoking immediately. Smoking is the single most damaging modifiable factor for egg quality. It damages mitochondrial DNA in eggs directly and accelerates follicular depletion. Even passive smoking has documented effects. This takes priority over every supplement.

For the full evidence-graded breakdown of egg quality supplements and lifestyle factors, see our dedicated guide on how to improve egg quality for IVF.

Sperm Quality Optimisation

IVF and especially ICSI success depends on sperm quality as much as egg quality. The same 90-day window applies to sperm development (spermatogenesis).

If you have not had a recent semen analysis, book one now. Key targets to check:

• Progressive motility 30% or above (WHO 2021 reference)
• Normal morphology (Kruger strict criteria) 4% or above
• Sperm DNA fragmentation (SDF) index below 15% (low risk); above 25% significantly impacts embryo development

What improves sperm quality:

• Quit smoking and eliminate recreational drugs
• Reduce alcohol to no more than 2-3 units per week
• Maintain scrotal temperature by avoiding hot baths, laptops on lap, and tight underwear
• CoQ10 (200-400mg/day) to support sperm mitochondria
• Antioxidants (Vitamin C, E, selenium, zinc) to reduce oxidative DNA damage
• Manage sleep and reduce sleep debt, as testosterone production occurs mainly during deep sleep

If a previous semen analysis showed abnormal results, request a sperm DNA fragmentation test before stimulation begins. High SDF is treatable with antioxidants and varicocele repair if present, and it is important to address before IVF rather than after a failed cycle.

See our guide on minimum sperm motility for IVF and ICSI for threshold values and what each parameter means.

Body Weight and Thyroid

BMI 19-29. Both underweight and overweight states impact hormone response. Underweight women may respond poorly to stimulation; overweight women require higher medication doses and have modestly lower success rates. A 5-10% weight change in 90 days can meaningfully affect outcome in patients at the edges of this range.

Thyroid function. Target TSH below 2.5 mIU/L before starting an IVF cycle. Subclinical hypothyroidism (TSH 2.5-4.5) is common and often asymptomatic but is associated with implantation failure and early pregnancy loss. A simple blood test and low-dose thyroid supplementation if needed can make a significant difference.

Diet

A Mediterranean-pattern diet is the most evidence-supported dietary approach for IVF outcomes, associated in multiple studies with higher clinical pregnancy rates. The core principles:

• Oily fish (sardines, mackerel, salmon) 2-3 times per week
• Leafy greens daily (palak, methi, drumstick leaves are excellent sources)
• Pulses and legumes (dal, chana, rajma) as primary protein sources
• Olive oil or cold-pressed oils over refined vegetable oil
• Whole grains over refined carbohydrates
• Limit red meat, processed foods, and added sugars
• Reduce ultra-processed snacks and trans fats

You do not need to eliminate all pleasurable eating. Moderate adherence to these principles is associated with benefit. Perfection is not required, and the stress of extreme dietary restriction may offset any nutritional gain.

Phase 2: Choosing the Right Clinic and Protocol

Lab quality is the most underestimated factor in IVF success. Embryos spend 3-6 days in an incubator between fertilisation and transfer. The quality of that environment, including temperature stability, CO2 and O2 levels, air filtration (volatile organic compounds are toxic to embryos), culture media composition, and handling protocols, has a larger impact on embryo development than most patients realise.

Success rate league tables are useful but have significant confounders such as patient selection, number of transfers reported, and fresh vs cumulative rates. When choosing a clinic, ask:

• What is your blastocyst formation rate from mature eggs retrieved?
• Do you use time-lapse incubators (continuous monitoring without disturbing embryos)?
• What air filtration system does your embryology lab use?
• What is your policy on elective single embryo transfer?

Protocol matching matters. There is no universally superior IVF stimulation protocol. The right protocol depends on your ovarian reserve, age, diagnosis, and previous response.

Your AMH test result and antral follicle count (AFC) are the two most important inputs for protocol selection. If you have not had AMH tested, do this before your first IVF consultation.

• Antagonist protocol (most common): Flexible, shorter, and with a lower OHSS risk. Preferred for normal and high responders, PCOS patients, and most under-40 patients.
• Long agonist (Lupron/Lupride) protocol: Better suppression of premature LH surge; still preferred for certain patients including some endometriosis cases and specific poor-responder patterns. Read our guide on Lupron and Lupride in IVF for a full protocol comparison.
• Mini-IVF / mild stimulation: Lower medication doses, fewer eggs, appropriate only for selected poor responders with low ovarian reserve.
• Natural cycle IVF: No stimulation medications; retrieves a single naturally dominant egg. Only appropriate for specific cases.

At Mamata Fertility in Hyderabad, the stimulation protocol is selected based on each patient’s AMH, antral follicle count (AFC), age, diagnosis, and body weight, not a one-size-fits-all approach.

If a previous IVF cycle did not work: The answer is not necessarily to try again. It is to find out why. Mamata Fertility’s Hyderabad team offers structured post-failure consultations that include ERA, PGT-A assessment, immunological testing review, and second-opinion protocol design before your next cycle.

Phase 3: During Stimulation, Compliance and Common Sense

Once stimulation begins, the most important thing you can do is comply precisely with the protocol and attend all monitoring appointments.

Medication timing matters. FSH injections should be taken within a one-hour window of the same time each day. Late or missed injections can alter follicular synchrony. GnRH antagonist injections (Cetrotide, Orgalutran) must be taken as directed to prevent premature ovulation.

Monitoring appointments are not optional. Ultrasound follicle counts and blood oestradiol levels on scheduled days allow your doctor to adjust stimulation doses in real time. Skipping even one scan can result in premature trigger or poor dose adjustment.

Rest and activity. Light walking, yoga (no inversions), and daily life activities are fine. Avoid:

• Intense cardio or weight training (increases ovarian torsion risk when ovaries are enlarged)
• Swimming in pools or the sea (infection risk post-retrieval)
• Hot baths, saunas, or steam rooms (temperature affects gamete quality)
• Sexual intercourse during stimulation (ovarian trauma risk with enlarged ovaries)

Hydration and OHSS prevention. Drink 2-3 litres of fluid daily during stimulation, including electrolyte drinks if your doctor recommends them. If you have PCOS, high AMH (above 3.5 ng/mL), or a previous OHSS episode, discuss OHSS risk management with your team before stimulation begins. See our safety guide on OHSS risk factors and symptoms.

Stress and IVF outcome. The evidence that psychological stress directly reduces IVF success rates is mixed. Several large meta-analyses have found no significant effect of measured stress on outcomes. What stress does do is reduce treatment adherence, worsen sleep, and degrade quality of life during an already difficult process. Manage stress for your own wellbeing, not because it will guarantee a better result.

Phase 4: Egg Retrieval and Embryo Development

You do not control what happens in the laboratory, but understanding it helps you make better decisions.

Retrieval Numbers vs Quality

More eggs is generally better, but beyond a certain point (typically 10-15 mature eggs), the marginal benefit of additional eggs decreases and OHSS risk increases. A retrieval of 8-12 mature eggs in a good responder is an excellent result.

Expected attrition from retrieval to blastocyst:

A cohort of 10 retrieved eggs might yield 5-7 mature eggs, 4-5 fertilised embryos, and 2-3 blastocysts, with possibly 1-2 euploid embryos confirmed by PGT-A if tested.

Blastocyst Grading

Embryos reaching the blastocyst stage on Day 5 or Day 6 are graded by three criteria: expansion (1-6), inner cell mass (A/B/C), and trophectoderm (A/B/C). A “4AA” blastocyst is fully expanded with excellent cell masses. A “3BB” has good potential. Even “3BC” or “4CB” blastocysts can and do result in healthy pregnancies. Grading predicts probability, not certainty.

PGT-A: Preimplantation Genetic Testing

PGT-A tests each blastocyst for chromosomal normality (euploidy) before transfer. It reduces miscarriage risk and improves per-transfer success rates, but does not increase the total number of euploid embryos (you cannot make aneuploid embryos become normal).

PGT-A adds most value for:

• Women over 37
• Recurrent pregnancy loss (2 or more miscarriages)
• Recurrent implantation failure (2 or more failed transfers with good embryos)
• Known chromosomal translocation in either partner

PGT-A is not recommended for all patients. In younger women with good embryo quality, transferring untested blastocysts sequentially may give equivalent cumulative success without the biopsy cost and the risk of discarding viable embryos misclassified as abnormal (false positive rate approximately 2-4%).

Phase 5: Transfer Strategy, Critical Decisions

Fresh transfer vs freeze-all. In a fresh cycle, the embryo is transferred 3-5 days after retrieval in the same cycle as stimulation. In a freeze-all strategy, all embryos are frozen and transferred in a subsequent natural or hormone-replacement cycle.

Evidence from multiple randomised trials (including the large POSEIDON and FROZEN trials) shows that freeze-all with FET (frozen embryo transfer) gives equal or better outcomes than fresh transfer in most patients. The reason is that stimulation medications alter the endometrial environment in ways that reduce receptivity, while a frozen transfer allows the uterus to return to a natural state.

Freeze-all is strongly preferred when:

• OHSS risk is high (PCOS, high follicle count, high oestradiol)
• Oestradiol level on trigger day is very high (above 3,000-4,000 pg/mL)
• Endometrial lining thickness or pattern is suboptimal
• ERA testing is planned (requires a mock cycle before transfer)
• PGT-A is being done (embryos must be frozen during biopsy processing)

Single embryo transfer (SET) vs double embryo transfer (DET). Medical bodies globally (including ICMR in India) recommend elective SET for good-prognosis patients, meaning patients under 37 with a good-quality blastocyst available. The reason is that twin pregnancies carry significantly higher maternal and neonatal risk (preterm birth, low birth weight, gestational diabetes, C-section) and do not meaningfully improve live birth rates per cycle when a quality blastocyst is available.

ERA (Endometrial Receptivity Analysis). ERA testing identifies the precise window of implantation: the hours in which your endometrium is maximally receptive to an embryo. It is not recommended for first-cycle patients and adds most value after 2 or more failed transfers with good embryos where a displaced implantation window is suspected.

Phase 6: The Two-Week Wait, What Evidence Says

The two-week wait (2WW) is the period between embryo transfer and the first pregnancy test. The evidence on what to do during this period is clear in some areas and ambiguous in others.

Evidence-based guidance:

• No bed rest required. Multiple randomised controlled trials have found no benefit to post-transfer bed rest. Normal light activity such as walking, desk work, and daily tasks is appropriate from transfer day.
• No high-impact exercise. Intense running, gym sessions with heavy lifting, and vigorous activities are best avoided for 2 weeks, not because they dislodge embryos (they do not), but as standard cautious practice.
• No hot baths or saunas. Elevated core temperature is best avoided during early embryo development and implantation.
• Continue all prescribed luteal phase support. Progesterone pessaries or injections, oestrogen tablets (in HRT-FET cycles), and any other prescribed medications must be taken exactly as directed. Stopping early is a common mistake.
• No sexual intercourse in the first 48-72 hours after transfer. After that, gentle sex is generally not contraindicated; discuss with your doctor.
• When to test: Blood beta-hCG is the definitive test and is most accurate from 10-12 days after a Day 5 blastocyst transfer. See our guide on home pregnancy tests after IVF for day-by-day guidance, including how to avoid false positives from residual hCG trigger.

What does not change outcomes (common myths):

• Eating pineapple core (bromelain) post-transfer: no clinical evidence
• Lying down for hours after transfer: no clinical benefit
• Visualisation and affirmations: valuable for wellbeing, not clinically proven to improve implantation
• Avoiding certain foods: no specific post-transfer dietary evidence; maintain your healthy eating pattern

What Not to Do: Common First-Cycle Mistakes

1. Starting preparation too late. Supplements and lifestyle changes begun one or two weeks before retrieval have minimal impact on egg quality. The 90-day window is not negotiable.

2. Ignoring sperm quality. Couples focus almost entirely on the woman’s preparation. Sperm quality, especially DNA fragmentation, is often the limiting factor in fertilisation and early embryo development and responds to the same 90-day intervention window.

3. Accepting a one-size-fits-all protocol. If your clinic uses the same stimulation protocol for everyone regardless of AMH, AFC, age, and diagnosis, ask why. Protocol individualisation is a basic standard of modern IVF care.

4. Choosing a clinic primarily on success rate claims. Published success rates are often self-reported, may include selected patient cohorts, and may reflect per-transfer rates (easier to inflate) rather than per-cycle live birth rates. Lab quality, embryologist experience, and patient volume are more reliable indicators.

5. Transferring a fresh embryo when a freeze-all would serve better. The pressure to get it done is understandable, but a transfer into a suboptimal endometrial environment wastes a good embryo. If your oestradiol is very high, your lining looks thin, or OHSS risk is elevated, freezing and waiting is the correct decision.

6. Transferring two embryos to improve chances. In good-prognosis patients, double embryo transfer does not double success rates. It approximately doubles twin risk. Twins are high-risk pregnancies, not a bonus.

7. Stopping progesterone support too early. Progesterone must be continued until at least 10-12 weeks of pregnancy. Stopping before this, even if the test is positive, risks luteal phase insufficiency. Follow your clinic’s specific instructions exactly.

8. Catastrophising after a difficult stimulation phase. Not every cycle produces the expected number of eggs. Quality matters more than quantity. One chromosomally normal blastocyst is worth more than five poor-quality Day 3 embryos.

When to Seek a Second Opinion?

Consider a second opinion before starting a first IVF cycle if:

• You have been recommended IVF without a full investigation of the cause of infertility
• You have been recommended a fixed stimulation protocol without explanation
• Your clinic has not discussed PGT-A, freeze-all, or ERA and you feel your case warrants these
• You have significant endometriosis, adenomyosis, uterine fibroids, or a known uterine anomaly, as these may require surgical treatment before IVF

If IVF does not succeed on the first attempt, a structured investigation before repeating the cycle is always worthwhile. See our guide on what to do if IVF fails for the investigation framework our Hyderabad team uses.